You are here: Industry Insights > Biologics

News List

Global Drug Innovation Trend and Its Market Landscape Shruiti Talashi
September 25, 2024
The creation of novel medications, treatments, and medical equipment that improve patient care and treatment results or outcomes is referred to as pharmaceutical innovation.
Research Progress on the Application of Biologics in Pediatric Asthma Xiaomichong
July 19, 2024
Asthma is a heterogeneous and complex chronic disease. Children with severe asthma often experience acute exacerbations, ultimately leading to impaired lung function and poor quality of life.
Common Treatments for Rheumatoid Arthritis David Orchard-Webb
July 01, 2024
Rheumatoid arthritis (RA) is a chronic inflammatory disorder that primarily affects joints but can also impact other systems in the body, including the skin, eyes, lungs, heart, and blood vessels.
Introduction of FDA Regulatory Education for Industry (REdI) Annual Conference 2021 Lin Zhang
August 16, 2021
There are many educational events in FDA throughout the year that focus on the pharmaceutical and regulatory industries.
Pharmaceutical News of the Week | CPhI.CN - Volumn-based Procurement PharmaSources/Caicai
August 06, 2020
According to the key content spread on the internet on July 28 regarding the national centralized procurement meeting held on July 24.
I-Mab Expands U.S. Footprint with New R&D Site in San Diego prnasia
October 25, 2021
I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that...
Eleva Reaches Industrial Production Scale and Prepares for Clinical Development of Factor H prnasia
September 23, 2021
Eleva, a manufacturer of superior biologics, is scaling up its production capacity to 2500 l in state-of-the-art single-use reactors. This will produce enough factor H to cover all three clinical phases.
Lumen Bioscience, Google Partner to Apply ML to Biologics Manufacturing contractpharma
August 12, 2021
Lumen Bioscience, a clinical-stage biopharma company, announced results from a research collaboration with Google that applied machine learning (ML) to significantly advance the scalability of spirulina-based biologic drugs.
Catalent Plans $100M Expansion of Biologics Mfg. Capabilities in Italy contractpharma
July 22, 2021
Initial phase includes installation of two 2,000-liter single-use bioreactors and associated investments to support early-and late-phase clinical development.
Fujifilm Invests $850M to Expand Biologics Capabilities contractpharma
July 02, 2021
Investment in CDMO business to add development and manufacturing capacity in US and UK.

Previous page 1 2 3 4 5 6 7 8 9 Next page